COMBINING PARASITE AND VECTOR COMPONENTS FOR DEVELOPMENT OF A LEISHMANIA VACCINE
$444,428N43FY2016AINIH
Pai Life Sciences, Inc., Seattle WA
Investigators
Abstract
To use sandfly and parasite antigens to develop a visceral leishmaniasis vaccine.
View original record on NIH RePORTER →